The novel coronavirus (SARS-CoV-19) was first identified in Wuhan, China in December 2019. Since that time, it has rapidly spread across the globe.  To help combat the epidemic, multiple testing techniques have been developed.  Such technologies include molecular and diagnostic assays which detect active infection as well as antibody tests that may identify if a person has been previously exposed to the virus.  In this webinar the process and science of the various testing strategies will be discussed as well as a look toward future testing techniques.

Learning Objectives:

• Differentiate between diagnostic and antibody tests for SARS-CoV-19.
• Describe the differences, pros, and cons between a nucleic acid and antigen diagnostic test.
• Given a patient case, identify the best SARS-CoV-19 test to use.

CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: October 7, 2023

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.